Plain-English translation of NCT05756322 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This trial is testing a new medication called to see if it can help people with acute leukemia (a serious blood cancer) that has returned or stopped responding to standard treatments. The study will first figure out the right dose and then test whether the medication works, either on its own or combined with other drugs. The main goal is to understand if this treatment is safe and what side effects patients might experience.
Acute leukemia is one of the most serious blood cancers, especially when it comes back or no longer responds to standard treatments. Many patients run out of options that work. This trial exists to see whether this medication could offer a new hope for people in this difficult situation.
You likely qualify if…
You likely don't qualify if…
You would visit the study clinic regularly to receive the medication and have blood tests and other checkups to monitor your health and response to treatment. The study has two phases: first, researchers will test different doses to find the safest and most effective amount, and then they will give that dose to more patients to confirm it works. Throughout your participation, you'll be closely watched for side effects and improvements in your condition.
AI-generated summary from trial data · Jul 15, 2026 · Not medical advice
United States